|
|
| |
5th
May 2009
Dolphin has added seven more formulations to its growing
Sri Lanka Portfolio
|
|
28th
April 2009
The Board of Directors of the Company in its 154th
meeting held on Tuesday, 28 April, 2009 has recommended 50% cash and 25% stock
dividend (bonus share)
|
|
|
 |
 |
 |
 |
 |
| D- Phenobarbitone Tablet |
|
| Back |
| COMPOSITION |
D- Phenobarbitone Tablet: Each tablet contains Phenobarbitone 30mg.
|
| INDICATIONS |
All forms of epilepsy, convulsions. |
| DOSEAGE & ADMINISTRATION |
|
Adult: 15-30mg 2 or 3 times daily. Maximum 600mg in 24 hours. Child: Up to 1 year
15-30mg daily; 1-12 years 30-60mg daily.
|
| CONTRAINDICATIONS |
|
Patients with a history of alcohol or drug abuse, acute intermittent prophyria.
|
| SIDE-EFFECTS |
|
Drowsiness, lethargoy, ataxia and allergic skin reactions; paradoxical excitement, restless and confusion in the elderly and hyperkinesias in children, megaloblastic anaemia.
|
| PRECAUTIONS |
|
Liver disorder, renal impairment severe pulmonary in sufficiency, the elderly and debilited , pregnancy, lactation. Tolerance and dependence may develop.
|
| STORAGE |
|
Store in a cool and dry place, protected from light.
|
| PACKAGING |
|
D- Phenobarbitone Tablet: Each carton contains 10x10 tablets in blister pack.
|
|
|
 |
 |
 |
 |
 |
 |
 |
|
|
